Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular Immunology

• Publication date

  2007-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MOLIMM.2007.05.004PMID 17597211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

  2007cited by this paper
• Molecular cloning and characterization of Toll-like receptor 9 in Japanese flounder, Paralichthys olivaceus.

  2007cited by this paper
• Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.

  2007cited by this paper
• Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.

  2007cited by this paper
• A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome

  2007cited by this paper
• Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.

  2006cited by this paper
• Clinical Aspects and Molecular Basis of Primary Deficiencies of Complement Component C3 and its Regulatory Proteins Factor I and Factor H

  2006cited by this paper
• Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

  2006cited by this paper
• Atypical haemolytic uraemic syndrome.

  2006cited by this paper
• Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.

  2005cited by this paper
• Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.

  2005cited by this paper
• The catalytically active serine protease domain of human complement factor I.

  2005cited by this paper
• Hemolytic Uremic Syndrome: An Example of Insufficient Complement Regulation on Self‐Tissue

  2005cited by this paper
• Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases.

  2004cited by this paper
• Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

  2004cited by this paper
• Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

  2003cited by this paper
• Familial haemolytic uraemic syndrome and an MCP mutation.

  2003cited by this paper
• Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries

  2003cited by this paper
• Ontogeny of Complement Regulatory Proteins – Concentrations of Factor H, Factor I, C4b‐Binding Protein, Properdin and Vitronectin in Healthy Children of Different Ages and in Adults

  2003cited by this paper
• The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura

  2002cited by this paper
• Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.

  2001cited by this paper
• Inherited Complete Factor I Deficiency Associated with Systemic Lupus Erythematosus, Higher Susceptibility to Infection and Low Levels of Factor H

  2001cited by this paper
• Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

  2001cited by this paper
• The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.

  2001cited by this paper
• Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.

  2000cited by this paper
• Glomerulonephritis in a patient with complement factor I deficiency.

  1999cited by this paper
• Complement Regulatory Proteins

  1999cited by this paper
• Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.

  1999cited by this paper
• Genetic studies into inherited and sporadic hemolytic uremic syndrome.

  1998cited by this paper
• Possible arrangement of the five domains in human complement factor I as determined by a combination of X-ray and neutron scattering and homology modeling.

  1998cited by this paper
• cDNA cloning, sequencing and chromosomal assignment of the gene for mouse complement factor I (C3b/C4b inactivator): identification of a species specific divergent segment in factor I.

  1996cited by this paper
• Processing of human factor I in COS-1 cells co-transfected with factor I and paired basic amino acid cleaving enzyme (PACE) cDNA.

  1995cited by this paper
• Characterization of Xenopus laevis complement factor I structure--conservation of modular structure except for an unusual insert not present in human factor I.

  1993cited by this paper
• Identity of the putative serine-proteinase fold in proteins of the complement system with nine relevant crystal structures.

  1993cited by this paper
• Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster.

  1991cited by this paper
• Horizons in Medicine

  1991cited by this paper
• Competition for binding sites on C3b by CR1, CR2, MCP, factor B and factor H.

  1990cited by this paper
• The multifunctional role of C3, the third component of complement.

  1988cited by this paper
• Human complement factor I: analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4.

  1987cited by this paper
• Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones.

  1987cited by this paper
• Phylogeny of C4b-C3b cleaving activity: similar fragmentation patterns of human C4b and C3b produced by lower animals.

  1987cited by this paper
• Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 Fragments for Factors B and H, complement receptors , and bovine conglutinin

  1983cited by this paper
• Complement biosynthesis by the human hepatoma-derived cell line HepG2.

  1982cited by this paper
• Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes

  1982cited by this paper
• Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity.

  1982cited by this paper
• Mouse C3b/C4b inactivator: purification and properties.

  1980cited by this paper
• Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b').

  1977cited by this paper
• Purification of C3b inactivator and demonstration of its two polypeptide chain structure.

  1977cited by this paper
• Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

  1977cited by this paper
• Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator.

  1976cited by this paper
• Cleavage products of C4b produced by enzymes in human serum.

  1975cited by this paper

• Eculizumab for Atypical Hemolytic Uremic Syndrome: Guidance for Developing Countries

  2025cites this paper
• Updates in atypical hemolytic syndrome.

  2025cites this paper
• Gene-Environment Interaction: Lessons From Complement-Mediated Kidney Disease.

  2025cites this paper
• A Case of Atypical Hemolytic Uremic Syndrome With a Complement Factor I Mutation Triggered by a Femoral Neck Fracture

  2025cites this paper
• Complete Complement Factor I (CFI) deficiency: a systematic review of forty-nine patients including three novel cases

  2025cites this paper
• Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort

  2024cites this paper
• C3 glomerulopathy is highly prevalent in French Polynesia

  2024cites this paper
• The Inhibitory Effects of a Factor B-Binding DNA Aptamer Family Supersede the Gain of Function of Factor B Variants Associated with Atypical Hemolytic Uremic Syndrome.

  2024cites this paper
• Atypical Hemolytic Uremic Syndrome: A Nationwide Colombian Pediatric Series

  2024cites this paper
• The role of complement factor I rare genetic variants in age related macular degeneration in Finland

  2024cites this paper
• Genetic Susceptibility in Endothelial Injury Syndromes after Hematopoietic Cell Transplantation and Other Cellular Therapies: Climbing a Steep Hill

  2024cites this paper
• Mutations in Atypical Hemolytic Uremic Syndrome Provide Evidence for the Role of Calcium in Complement Factor I.

  2023cites this paper
• Complement dysregulation associated with a genetic variant in factor H-related protein 5 in atypical hemolytic uremic syndrome

  2023cites this paper
• Functional evaluation of complement factor I variants by immunoassays and SDS-PAGE

  2023cites this paper
• Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic.

  2023cites this paper
• Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN

  2023cites this paper
• CNS Inflammation as the First Sign of Complement Factor I Deficiency

  2023cites this paper
• Rare complement factor I variants associated with reduced macular thickness and age-related macular degeneration in the UK Biobank

  2022cites this paper
• Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside

  2022cites this paper
• Functional Analysis of Variants in Complement Factor I Identified in Age-Related Macular Degeneration and Atypical Hemolytic Uremic Syndrome

  2022cites this paper
• A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report

  2022cites this paper
• A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in age-related macular degeneration

  2022influential citation
• Syndrome hémolytique et urémique atypique: aspects génétiques et physiopathologiques

  2022cites this paper
• Functional Analysis of Rare Genetic Variants in Complement Factor I (CFI) in Advanced Age-related Macular Degeneration (AMD).

  2022cites this paper
• An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access

  2022cites this paper
• Prevalence and phenotype associations of complement factor I mutations in geographic atrophy

  2021cites this paper
• FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy

  2021cites this paper
• Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification

  2021cites this paper
• A rare cause of recurrent acute kidney injury in a 3-year-old girl: Answers

  2021influential citation
• Implications of genetic variation in the complement system in age-related macular degeneration.

  2021cites this paper
• Atypical Hemolytic Uremic Syndrome After Kidney Transplantation: Lessons Learned From the Good, the Bad, and the Ugly. A Case Series With Literature Review.

  2020cites this paper
• Atypical hemolytic uremic syndrome: a case report

  2020cites this paper
• The familial risk of developing atypical Hemolytic Uremic Syndrome.

  2020cites this paper
• Effect of rare coding variants in the CFI gene on Factor I expression levels

  2020cites this paper
• Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration

  2020cites this paper
• Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium.

  2020cites this paper
• Cocaine‐associated atypical haemolytic uraemic syndrome in a genetically susceptible individual

  2020cites this paper
• Plasma C3d levels as a diagnostic marker for complete complement factor I deficiency.

  2020cites this paper
• Functional Analysis of Rare Genetic Variants in Complement Factor I (CFI) using a Serum-Based Assay in Advanced Age-related Macular Degeneration

  2020cites this paper
• CFHR5 Genetic Variations and Serum Levels in Patients with Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy

  2020cites this paper
• Complement deficiencies.

  2020cites this paper
• Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies

  2019cites this paper
• Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility

  2019cites this paper
• A Multimodality Approach to Assessing Factor I Genetic Variants in Atypical Hemolytic Uremic Syndrome

  2019cites this paper
• Atypical hemolytic–uremic syndrome: recurrent phenotypic expression of a patient with MCP gene mutation combined with risk haplotypes

  2019cites this paper
• Atipični hemolitičko-uremijski sindrom

  2019cites this paper
• Pathogenesis of Atypical Hemolytic Uremic Syndrome

  2019cites this paper
• Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS

  2019cites this paper
• Studies of rare genetic variants in age-related macular degeneration

  2018cites this paper
• Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I

  2018cites this paper
• Chapter 15 – Factor I

  2018cites this paper
• Diseases of complement dysregulation—an overview

  2018cites this paper
• The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment

  2017cites this paper
• A/E Attaching and Effacing AP-1 Activator Protein-1 BF Factor B CCP Complement Control Protein CFHR Complement Factor H Related proteins CSF-1 Colony Stimulating Factor-1 D+HUS Diarrhoea-associated Haemolytic Ura- emic Syndrome DRM Detergent Resistant Membranes EDTA Ethylenediaminetetra-acetic Acid

  2017cites this paper
• Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea

  2017cites this paper
• Hemolytic Uremic Syndrome in Pregnancy and Postpartum.

  2017cites this paper
• Clinical laboratory standard capillary protein electrophoresis alerted of a low C3 state and lead to the identification of a Factor I deficiency due to a novel homozygous mutation.

  2016cites this paper
• Complement abnormalities in membranoproliferative glomerulonephritis and C3 glomerulopathy

  2016cites this paper
• Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation

  2016cites this paper
• TNF Regulates Essential Alternative Complement Pathway Components and Impairs Activation of Protein C in Human Glomerular Endothelial Cells

  2016cites this paper
• Adjustment of Eculizumab Dosage Pattern in Patients with Atypical Hemolytic Uremic Syndrome with Suboptimal Response to Standard Treatment Pattern

  2016cites this paper
• Thrombotic microangiopathy without renal involvement: two novel mutations in complement‐regulator genes

  2016cites this paper
• Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.

  2016cites this paper
• Comprehensive Analysis of Complement Genes in Patients with Atypical Hemolytic Uremic Syndrome

  2016cites this paper
• Post-bone marrow transplant thrombotic microangiopathy

  2016cites this paper
• Atypical aHUS: State of the art.

  2015cites this paper
• The role of the complement system in the hemolytic uremic syndrome

  2015cites this paper
• Genetics of atypical haemolytic uraemic syndrome

  2015cites this paper
• Human thrombomodulin regulates complement activation as well as the coagulation cascade in xeno‐immune response

  2015cites this paper
• Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels

  2015cites this paper
• Atypical Hemolytic Uremic Syndrome Post-Kidney Transplantation: Two Case Reports and Review of the Literature

  2014influential citation
• Complement Factor H-Antibody–Associated Hemolytic Uremic Syndrome: Pathogenesis, Clinical Presentation, and Treatment

  2014cites this paper
• O papel do Sistema Complemento no Síndrome Hemolítico Urémico Atípico

  2014cites this paper
• Atypical Hemolytic Uremic Syndrome

  2014cites this paper
• Syndrome hémolytique et urémique atypique : pour qui l’éculizumab ?

  2014cites this paper
• Protecting the kidney from complement: atypical haemolytic uraemic syndrome.

  2014cites this paper
• Deficiencies of the Complement System

  2014cites this paper
• Genetics of Atypical Hemolytic Uremic Syndrome (aHUS)

  2014cites this paper
• Hemolytic uremic syndrome

  2014cites this paper
• Cardiovascular complications in atypical haemolytic uraemic syndrome

  2014cites this paper
• Atypical haemolytic uraemic syndrome

  2014cites this paper
• Natural History of Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome

  2014cites this paper
• Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.

  2013cites this paper
• Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.

  2013cites this paper
• Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration

  2013cites this paper
• Case series: hemolytic uremic syndrome--another cause of transplant dysfunction.

  2013cites this paper
• Complete Factor I Deficiency Due to Dysfunctional Factor I with Recurrent Aseptic Meningo-Encephalitis

  2013cites this paper
• The Complement Cascade and Renal Disease

  2013cites this paper
• Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

  2013cites this paper
• Hemolytic Uremic Syndrome after Kidney Transplantation: Therapeutic Alternatives

  2013cites this paper
• Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations

  2013cites this paper
• Transcriptome characterization by RNA-Seq reveals the involvement of the complement components in noise-traumatized rat cochleae.

  2013cites this paper
• Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases

  2013cites this paper
• Complement therapy in atypical haemolytic uraemic syndrome (aHUS)

  2013cites this paper
• Crosstalk between platelets and the complement system in immune protection and disease

  2013cites this paper
• eview omplement therapy in atypical haemolytic uraemic syndrome ( aHUS ) dwin

  2013cites this paper
• Atypical Hemolytic Uremic Syndrome

  2013cites this paper
• Factor I mutation in Tunisian patient with atypical hemolytic uremic syndrome

  2013influential citation
• Complement autoantibodies in atypical haemolytic uraemic syndrome and IgA nephropathy

  2013cites this paper
• Facteurs prédictifs de récidive et de sévérité du syndrome hémolytique et urémique atypique et de la glomérulonéphrite à C3 après transplantation rénale

  2013cites this paper